Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ranibizumab for neovascular age-related macular degeneration.

× No keyword cloud information.

15 in total

1. Treatment of exudative age-related macular degeneration: many factors to consider.

Authors: Timothy W Olsen
Journal: Am J Ophthalmol Date: 2007-08 Impact factor: 5.258

2. [Age-related macular degeneration and risk of stroke].

Authors: V Biousse; M-G Bousser; A Gaudric
Journal: J Fr Ophtalmol Date: 2008-01 Impact factor: 0.818

Review 3. The treatment of wet age-related macular degeneration.

Authors: Antonia M Joussen; Norbert Bornfeld
Journal: Dtsch Arztebl Int Date: 2009-05-01 Impact factor: 5.594

4. Epimacular brachytherapy - old ghost or new age?

Authors: Norbert Bornfeld
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-02-20 Impact factor: 3.117

Review 5. Anti-VEGF therapies and blood pressure: more than meets the eye.

Authors: Frank Enseleit; Stephan Michels; Frank Ruschitzka
Journal: Curr Hypertens Rep Date: 2010-02 Impact factor: 5.369

Review 6. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.

Authors: Jing Xie; M Kamran Ikram; Mary Frances Cotch; Barbara Klein; Rohit Varma; Jonathan E Shaw; Ronald Klein; Paul Mitchell; Ecosse L Lamoureux; Tien Yin Wong
Journal: JAMA Ophthalmol Date: 2017-06-01 Impact factor: 7.389

7. Adverse gastrointestinal events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study.

Authors: Robert J Campbell; Chaim M Bell; Susan E Bronskill; J Michael Paterson; Marlo Whitehead; Erica de L Campbell; Sudeep S Gill
Journal: Drug Saf Date: 2014-09 Impact factor: 5.606

8. Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration.

Authors: Sobha Sivaprasad
Journal: Clin Ophthalmol Date: 2008-06

Review 9. Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors: Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal: Drugs Aging Date: 2009 Impact factor: 3.923

10. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.

Authors: Xinyuan Zhang; Shisan Bao; Donna Lai; Robert W Rapkins; Mark C Gillies
Journal: Diabetes Date: 2008-01-03 Impact factor: 9.461